Obatala Sciences
Driving Diversity in Research. Impacting the Future.


About us



Obatala Sciences is a biotechnology company that offers research enabling products and brain power to scientists in industry and academia with the goal of advancing tissue engineering and regenerative medicine.

We are a team of thought leaders with the common goal of advancing our mission: promoting diversity to advance the study and prevention of diseases in the fields of obesity, diabetes, tissue engineering, and regenerative medicine.



To enable faster and safer delivery of innovative therapies that improve quality of life for all patients
regardless of ethnic backgrounds.

The Team


President and CEO

Trivia Frazier, PhD, MBA

Dr. Frazier received her Ph.D. from Tulane University School of Medicine, graduating from the Biomedical Sciences Program in 2012. Her dissertation training projects involved the use of cryopreserved adult mesenchymal stem cells derived from adipose tissue for clinical use in tissue reconstruction and regenerative medicine applications. She has held tenure-track faculty positions at Delgado Community College and served as Program Chair in the Chemistry and Chemical Technology Department at Dillard University.


To review Dr. Frazier’s published work, please click here.


Board Member and Co-Founder

Jeffrey Gimble, MD, PhD

Dr. Gimble received his M.D. and Ph.D. from Yale University, where he began his 30+ year research career. During this time, he has held several full-time and adjunct faculty positions, and has biotechnology industry experience on staff at Zen-Bio and as a co-founder of Artecel Sciences. Dr. Gimble’s professional career has focused on the isolation, characterization, and clinical translation of stromal/stem cells from adipose tissue, bone, and bone marrow, resulting in more than 200 published manuscripts. Together with Dr. Wu, he co-founded LaCell LLC to provide this expertise to the broader academic and biotech research communities.


To review Dr. Gimble’s published work, please click here.


Board Member / Co-Founder / Director of Research

Xiying Wu, MD

Dr. Wu received her Medical Degree from the Medical school of Jilin University in Changchun, China. After eight years of basic biomedical research in China, Dr. Wu decided to pursue an advanced biomedical research in the United States. She joined Dr. Gimble’s lab at Oklahoma Medical Research Foundation in 1991, began long time collaboration with Dr. Gimble.

Since, Dr. Wu has worked in stromal/stem cell research in and out of academia, has co-authored over 50 manuscripts with Dr. Gimble. In 2012, she moved to a full-time position as Vice President of Research & Development at LaCell LLC. Dr. Wu plays an integral role in determining LaCell’s commercial and scientific direction.


To review Dr. Wu’s published work, please click here.

david bode-20.png

Director of Commercialization

David Bode, MBA

David received his MBA from Tulane University's Freeman School of Business. Prior to joining Obatala Sciences, David assisted biotech, health IT, and clean energy startups at the New Orleans BioInnovation Center. David manages business development, strategy, and operations for Obatala Sciences.


Laboratory Manager

Andrea Alarcon, BS

Andrea Alarcon earned her Bachelor of Science in Biological Sciences from Loyola University New Orleans in 2017. At Loyola, she worked as a Research Assistant under Dr. Kimberlee Mix on the investigation of novel therapeutic targets for rheumatoid arthritis, specifically in the role of nuclear receptor 4A2 factor in joint tissues.

Her research focused on the histological analysis of joint tissues of mouse models of arthritis, as well as on the immunohistochemical analysis of the expression of the NR4A2 protein in the joints. Prior to her current job, she briefly worked for an environmental company based in Atlanta as Laboratory Analyst. Andrea is currently working at LaCell, LLC as a Research Technician, assisting the company in several projects.

Advisory Board Members


Ken Eilertsen, PhD


Shafin Khan, JD


Frank Greenway III, MD


Elizabeth Floyd, PhD


Gregory Domingue, PE, MBA